Celgene (CELG) Balance Sheet

Current and historical balance sheet items (assets, liabilities and equity) for Celgene (CELG) over the last 10 years.

Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $99.867B $11.229B
Celgene Corp. is an independent biopharmaceutical company engaged primarily in the discovery, development and commercialization of orally administered, small molecule drugs for the treatment of cancer and immunological diseases.